344 related articles for article (PubMed ID: 14511383)
1. Human proteoglycan testican-1 inhibits the lysosomal cysteine protease cathepsin L.
Bocock JP; Edgell CJ; Marr HS; Erickson AH
Eur J Biochem; 2003 Oct; 270(19):4008-15. PubMed ID: 14511383
[TBL] [Abstract][Full Text] [Related]
2. Dual concentration-dependent activity of thyroglobulin type-1 domain of testican: specific inhibitor and substrate of cathepsin L.
Meh P; Pavsic M; Turk V; Baici A; Lenarcic B
Biol Chem; 2005 Jan; 386(1):75-83. PubMed ID: 15843150
[TBL] [Abstract][Full Text] [Related]
3. Saxiphilin, a saxitoxin-binding protein with two thyroglobulin type 1 domains, is an inhibitor of papain-like cysteine proteinases.
Lenarcic B; Krishnan G; Borukhovich R; Ruck B; Turk V; Moczydlowski E
J Biol Chem; 2000 May; 275(20):15572-7. PubMed ID: 10748022
[TBL] [Abstract][Full Text] [Related]
4. Major histocompatibility complex class II-associated p41 invariant chain fragment is a strong inhibitor of lysosomal cathepsin L.
Bevec T; Stoka V; Pungercic G; Dolenc I; Turk V
J Exp Med; 1996 Apr; 183(4):1331-8. PubMed ID: 8666891
[TBL] [Abstract][Full Text] [Related]
5. Testican-1: a differentially expressed proteoglycan with protease inhibiting activities.
Edgell CJ; BaSalamah MA; Marr HS
Int Rev Cytol; 2004; 236():101-22. PubMed ID: 15261737
[TBL] [Abstract][Full Text] [Related]
6. Potency and selectivity of inhibition of cathepsin K, L and S by their respective propeptides.
Guay J; Falgueyret JP; Ducret A; Percival MD; Mancini JA
Eur J Biochem; 2000 Oct; 267(20):6311-8. PubMed ID: 11012686
[TBL] [Abstract][Full Text] [Related]
7. Development of peptidyl alpha-keto-beta-aldehydes as new inhibitors of cathepsin L--comparisons of potency and selectivity profiles with cathepsin B.
Lynas JF; Hawthorne SJ; Walker B
Bioorg Med Chem Lett; 2000 Aug; 10(15):1771-3. PubMed ID: 10937745
[TBL] [Abstract][Full Text] [Related]
8. Plasmodium falciparum: inhibitors of lysosomal cysteine proteinases inhibit a trophozoite proteinase and block parasite development.
Rosenthal PJ; McKerrow JH; Rasnick D; Leech JH
Mol Biochem Parasitol; 1989 Jun; 35(2):177-83. PubMed ID: 2671722
[TBL] [Abstract][Full Text] [Related]
9. Bombyx cysteine proteinase inhibitor (BCPI) homologous to propeptide regions of cysteine proteinases is a strong, selective inhibitor of cathepsin L-like cysteine proteinases.
Kurata M; Yamamoto Y; Watabe S; Makino Y; Ogawa K; Takahashi SY
J Biochem; 2001 Dec; 130(6):857-63. PubMed ID: 11726287
[TBL] [Abstract][Full Text] [Related]
10. The novel bovine serpin endopin 2C demonstrates selective inhibition of the cysteine protease cathepsin L compared to the serine protease elastase, in cross-class inhibition.
Hwang SR; Stoka V; Turk V; Hook VY
Biochemistry; 2005 May; 44(21):7757-67. PubMed ID: 15909990
[TBL] [Abstract][Full Text] [Related]
11. The slow-binding inhibition of cathepsin K by its propeptide.
Billington CJ; Mason P; Magny MC; Mort JS
Biochem Biophys Res Commun; 2000 Oct; 276(3):924-9. PubMed ID: 11027570
[TBL] [Abstract][Full Text] [Related]
12. The SEP domain of p47 acts as a reversible competitive inhibitor of cathepsin L.
Soukenik M; Diehl A; Leidert M; Sievert V; Büssow K; Leitner D; Labudde D; Ball LJ; Lechner A; Nägler DK; Oschkinat H
FEBS Lett; 2004 Oct; 576(3):358-62. PubMed ID: 15498563
[TBL] [Abstract][Full Text] [Related]
13. Hurpin is a selective inhibitor of lysosomal cathepsin L and protects keratinocytes from ultraviolet-induced apoptosis.
Welss T; Sun J; Irving JA; Blum R; Smith AI; Whisstock JC; Pike RN; von Mikecz A; Ruzicka T; Bird PI; Abts HF
Biochemistry; 2003 Jun; 42(24):7381-9. PubMed ID: 12809493
[TBL] [Abstract][Full Text] [Related]
14. Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease.
Shi GP; Munger JS; Meara JP; Rich DH; Chapman HA
J Biol Chem; 1992 Apr; 267(11):7258-62. PubMed ID: 1373132
[TBL] [Abstract][Full Text] [Related]
15. Selective suppression of cathepsin L results from elevations in lysosomal pH and is followed by proteolysis of tau protein.
Bednarski E; Lynch G
Neuroreport; 1998 Jun; 9(9):2089-94. PubMed ID: 9674599
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory mediators regulate cathepsin S in macrophages and microglia: A role in attenuating heparan sulfate interactions.
Liuzzo JP; Petanceska SS; Moscatelli D; Devi LA
Mol Med; 1999 May; 5(5):320-33. PubMed ID: 10390548
[TBL] [Abstract][Full Text] [Related]
17. Molecular Features of CA-074 pH-Dependent Inhibition of Cathepsin B.
Yoon MC; Christy MP; Phan VV; Gerwick WH; Hook G; O'Donoghue AJ; Hook V
Biochemistry; 2022 Feb; 61(4):228-238. PubMed ID: 35119840
[TBL] [Abstract][Full Text] [Related]
18. Phenytoin and cyclosporin A suppress the expression of MMP-1, TIMP-1, and cathepsin L, but not cathepsin B in cultured gingival fibroblasts.
Yamada H; Nishimura F; Naruishi K; Chou HH; Takashiba S; Albright GM; Nares S; Iacopino AM; Murayama Y
J Periodontol; 2000 Jun; 71(6):955-60. PubMed ID: 10914799
[TBL] [Abstract][Full Text] [Related]
19. Aziridine analogs of [[trans-(epoxysuccinyl)-L-leucyl]amino]-4-guanidinobutane (E-64) as inhibitors of cysteine proteases.
Martichonok V; Plouffe C; Storer AC; Ménard R; Jones JB
J Med Chem; 1995 Aug; 38(16):3078-85. PubMed ID: 7636871
[TBL] [Abstract][Full Text] [Related]
20. New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid.
Schirmeister T
J Med Chem; 1999 Feb; 42(4):560-72. PubMed ID: 10052963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
